Graphic abstract

Research Paper
The prognostic role of the preoperative platelet to lymphocyte ratio in laryngeal cancer
Qin Li, Mengqi Chen, Lamei Xiao, Huaqin Zhao
J. Cancer 2023; 14(16): 2990-2997. doi:10.7150/jca.87397
[Abstract] [Full text] [PDF]


Graphic abstract

Research Paper
Formin protein FMNL1 is a biomarker for tumor-infiltrating immune cells and associated with well immunotherapeutic response
Guomin Lu, Hui Wang, Rui Xu, Junying Xu, Fangmei An, Haoran Xu, He Nie, Jie Mei, Qiang Zhan, Qinglin Zhang
J. Cancer 2023; 14(16): 2978-2989. doi:10.7150/jca.86965
[Abstract] [Full text] [PDF]


Graphic abstract

Research Paper
Suppression of Wnt/β-catenin Signaling in PDAC via METTL16-mediated N6-methyladenosine Modification of DVL2
Lanting Yu, Jiawei Lu, Ni Xie, Lutong Fang, Sumin Chen, Ying Wu, Xingpeng Wang, Baiwen Li
J. Cancer 2023; 14(16): 2964-2977. doi:10.7150/jca.85860
[Abstract] [Full text] [PDF]


Graphic abstract

Review
The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events due to Immune Checkpoint Inhibitors: a Systematic Review
Antonio Pizuorno Machado, Hunter Ratliff, Ahmed Abdelwahab, Muhammad H. Vohra, Andrew Kuang, Malek Shatila, Muhammad Ali Khan, Menhaz A. Shafi, Anusha S. Thomas, Jessica Philpott, Omar Alhalabi, Yinghong Wang
J. Cancer 2023; 14(16): 2956-2963. doi:10.7150/jca.87335
[Abstract] [Full text] [PDF]


Graphic abstract

Research Paper
The alterations in peripheral lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in hepatocellular carcinoma
Qu Xie, Can Hu, Cong Luo
J. Cancer 2023; 14(15): 2946-2955. doi:10.7150/jca.88101
[Abstract] [Full text] [PDF]


Graphic abstract

Research Paper
S100A10 Overexpression Correlates with Adverse Prognosis, Tumor Microenvironment, and Aggressive Behavior In Vitro and In Vivo of Cervical Cancer
Yue-Chen Zhao, Tie-Jun Wang, Li-Zhen She, Jie Cui, Chao-He Zhang
J. Cancer 2023; 14(15): 2931-2945. doi:10.7150/jca.87689
[Abstract] [Full text] [PDF]


Graphic abstract

Research Paper
Characteristics of m6A-related LncRNAs in breast cancer as prognostic biomarkers and immunotherapy
Xinwei Han, Yu Chen, Jiaogui Xie, Yichao Wang
J. Cancer 2023; 14(15): 2919-2930. doi:10.7150/jca.87079
[Abstract] [Full text] [PDF]


Graphic abstract

Research Paper
Abnormal expressions of PURPL, miR-363-3p and ADAM10 predicted poor prognosis for patients with ovarian serous cystadenocarcinoma
Ruitao Zhang, Xueying Guo, Limin Zhao, Tingting He, Wei Feng, Shumin Ren
J. Cancer 2023; 14(15): 2908-2918. doi:10.7150/jca.87405
[Abstract] [Full text] [PDF]

More ...

Cover image

Indexed in PubMed and SCI expanded; full texts in PubMed Central and Europe PMC. ...


A note on plagiarism (please read before submission): There is a zero-tolerance policy towards plagiarism in this journal. Manuscripts are screened for plagiarism at any stages. If a manuscript is already published and plagiarism is still detected or later reported by readers, it will be retracted and the authors' institutions and department heads will be notified to take actions. This includes data fabrication and image manipulation.


Journal of Genomics recent articles:

Research Paper
Isolation and draft genome sequence of Paenibacillus sp. CCS19
Hironaga Akita, Yoshiki Shinto, Zen-ichiro Kimura
J. Genomics 2023; 11: 45-47. doi:10.7150/jgen.87228
[Abstract] [Full text] [PDF]


JCA Top cited papers:

  • Anahid Jewett, et al. Dual Functions of Natural Killer Cells in Selection and Differentiation of Stem Cells; Role in Regulation of Inflammation and Regeneration of Tissues. Cited by 62
  • Jan Trøst Jørgensen, Maria Hersom. HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature. Cited by 204
  • Chikezie O. Madu, Yi Lu. Novel diagnostic biomarkers for prostate cancer. Cited by 223
  • Ohtani H, et al. A meta-analysis of the short-and long-term results of randomized controlled trials that compared laparoscopy-assisted and conventional open surgery for colorectal cancer. Cited by 167
  • Dario Sangiolo. Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors. Cited by 193
  • Sara A. Lari, Henry M. Kuerer. Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review. Cited by 131